Applied Therapeutics Reports First Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: May 13, 2025
- Company to present full 12-month clinical data and new topline 18-month and 24-month data from INSPIRE registrational Phase 3 trial of govorestat in CMT-SORD Deficiency at the Peripheral Nerve Society 2025 Annual Meeting
Read more at globenewswire.com
